2. Are data reliable and complete?
|
|
- Howard Harper
- 5 years ago
- Views:
Transcription
1 2. Are data reliable and complete? Tom Hiatt WHO/HQ/Stop TB TB monitoring and evaluation unit
2
3 Data quality: what is it? 1. Data Quality: The Accuracy Dimension Jack E. Olson "Data has quality if it satisfies the requirements of its intended use. It lacks quality to the extent that it does not satisfy the requirement. In other words, data quality depends as much on the intended use as it does on the data itself. To satisfy the intended use, the data must be accurate, timely, relevant, complete, understood, and trusted." Definition of Data Quality US Census Bureau "Fitness for use. To be fit for use, data products must possess all three attributes of quality defined by the Office of Management and Budget: 1) Utility - refers to the usefulness of the information for its intended users. 2) Objectivity - refers to whether information is accurate, reliable, and unbiased, and is presented in an accurate, clear, and unbiased manner. 3) Integrity - refers to the security or protection of information from unauthorized access or revision."
4 Intended use of TB notification data Estimate of TB incidence Estimate of trend in TB incidence over time
5 Afghanistan Bahrain Djibouti Egypt Iran Iraq Jordan Kuwait Lebanon Libya Morocco Oman Pakistan Qatar Saudi Arabia 15 Somalia Sudan Syria Tunisia UAE WB and GS Yemen Saudi Arabia, Tunisia, Egypt, Iraq, Libya, Sudan, Oman, Kuwait, Pakistan, Somalia, Syria, UAE, Djibouti, Lebanon, Morocco, Yemen, Bahrain, Jordan, Afghanistan, Qatar, West Bank and Gaza, Iran
6 2.1 Are TB data complete? Do the nationally aggregated TB notifications include all the data/reports from the reporting units that were expected to report to NTP? Were any notification reports missing from the lowest admin levels at any time? 2.2 Are TB data reliable? Are reported TB cases actually TB cases? Are TB cases classified correctly? e.g. new cases are not classified as re-treatment or vice versa. Or smear unknown cases are not classified as smear-negative.
7 Assessing quality: system vs. data System (M&E, HIS) Data M & E strengthening tool» (MEASURE Evaluation) Performance of Routine HIS tool» (JSI) HIS assessment tool» (Health Metrics Network) Record reviews (DQA tools by Measure and GAVI) Analytical approaches Population based data Commodities Models Patterns and trends
8 In god we trust, all others bring data! Rex Davenport
9 Comparison of reports received versus expected & 2.1.2: Do you have a system to monitor the completeness of reporting from admin 1 to national level? If yes, since when)?
10 Comparison of reports received versus expected & 2.1.4: Do you have a system to monitor the completeness of reporting from admin 2 to admin 1 level? If yes, since when? & 2.1.6: Do you have a system to monitor the completeness of reporting from admin 3 to admin 2 level? If yes, since when?
11 Identification of unusual fluctuations 2.1.7: Were there unusual fluctuations in the time series? Pakistan Iraq??? Egypt? Djibouti
12 Identification of unusual fluctuations 2.1.7: Were there unusual fluctuations in the time series?
13 Identification of unusual fluctuations 2.1.8: If yes, can you list the reasons for these unusual fluctuations in time? Sudden improvements or disruptions in the recording and reporting system Inclusion of data from new reporting units Sudden changes in TB diagnostic capacity Changes in notified case definitions Don't know Other. Please specify.
14 Identification of unusual fluctuations Do you think that the fluctuations were driven by a certain case type?
15 Identification of unusual fluctuations Do you think that the fluctuations were driven by a certain case type? Yes, it was manly driven by fluctuations in the number of SS+ pulmonary TB cases Yes, it was manly driven by fluctuations in the number of SS- pulmonary TB cases Yes, it was manly driven by fluctuations in the number of extra-pulmonary TB cases No, I don't believe the fluctuations were driven by a certain case type. Don't know Other. Please specify.
16 Variation in notification rates of new TB cases across admin Is there a lot of variation between notification rates of new (all and by smear) TB cases across admin1? ~ 140 ~ 0
17 Variation in notification rates of new TB cases across admin If yes, what are the main reasons to explain this variation? True differences in TB epidemic sub-nationally Differences in TB diagnostic capacity Differences in the recording and reporting system Don't know Other. Please specify.
18 Variation in notification rates of new TB cases across admin Do you think that the fluctuations found for the national data were driven by certain admin 1 areas?
19 Comparison notifications workshop template versus reported in WHO TB database Was there a difference between the number of notifications reported in the workshop template and those reported in the WHO Global TB database?
20 Comparison notifications workshop template versus reported in WHO TB database If yes, can you list the reasons for this difference? Case definition understood as different in each database Inclusion of reports that arrived late Don't know Other. Please specify.
21 Comparison national and subnational notification data in the workshop template & : Was there a difference between the national aggregated data with the subnational data reported in the workshop template? If yes, can you explain the reasons for this difference?
22 2.2 Are TB data reliable? Are reported TB cases actually TB cases? Are cases classified correctly?
23 Relapse Retreat / National Pulm New SS+ Pulm / / New All /
24 A - Proportion of all TB cases that are new In the last year, how does the proportion compare with the global and regional average? / New All
25 A - Proportion of all TB cases that are new If the proportion is higher or smaller than the global average, how do you explain this? Factors that interfere with the number of retreatment cases, including differences in risk factors, TB control efforts, proportion of drug-resistant TB Misclassification problems (i.e. retreatment cases classified as new cases) Don't know Other causes - please specify / New All
26 A - Proportion of all TB cases that are new & 2.2.4: Are there significant variations over time? If yes, how do you explain these variations over time? Variations in the factors that interfere with the number of retreatment cases, including TB control efforts, proportion of drug-resistant TB Reduction of misclassification problems (i.e. retreatment cases no longer classified as new cases) Don't know Other causes - please specify / New All
27 B - Proportion of new cases that are pulmonary In the last year, how does the proportion compare with the global and regional average? / Pulm New
28 B - Proportion of new cases that are pulmonary If the proportion is higher or smaller than the global average, how do you explain this? Differences in extra-pulmonary TB diagnostic capacity Differences in the age structure of TB cases Differences in HIV prevalence Differences in notification policy or practice Misclassification problems Don't know / Pulm New
29 B - Proportion of new cases that are pulmonary & 2.2.8: Are there significant variations over time? If yes, how do you explain these variations over time? Variations in extra-pulmonary TB diagnostic capacity Variations in the age structure of TB cases Variations in HIV prevalence Variations in notification policy/practice Variations in misclassification problems (introduction of measures to correct the misclassification problem) Don't know Other causes - please specify / Pulm New
30 C - Proportion of all pulmonary cases that are smear positive In the last year, how does the proportion compare with the global and regional average? / SS+ Pulm
31 C - Proportion of all pulmonary cases that are smear positive / SS+ Pulm
32 C - Proportion of all pulmonary cases that are smear positive If the proportion is higher or smaller than the global average, how do you explain this? Differences in capacity to perform smear examination Differences in the age structure of TB cases Differences in HIV prevalence Differences in notification policy or practice Misclassification problems Don't know Other causes - please specify / SS+ Pulm
33 C - Proportion of all pulmonary cases that are smear positive & : Are there significant variations over time? If yes, how do you explain these variations over time? You can select more than one. Variations in diagnostic capacity for smear positive cases Variations in the age structure of TB cases Variations in HIV prevalence Variations in notification policy/practice Variations in misclassification problems (introduction of measures to correct the misclassification problem) Don't know Other causes - please specify / SS+ Pulm
34 D - Proportion of all re-treatment cases that are 1) relapse, 2) treatment-after-failure, 3) treatment-after-default 4) other retreatment In the last year, which of the categories contributed most to the total number of retreatment cases? Relapse Treatment-after-failure Treatment-after-default Other re-treatment / Relapse Retreat
35 D - Proportion of all re-treatment cases that are 1) relapse, 2) treatment-after-failure, 3) treatment-after-default 4) other retreatment & Where there significant changes over time in the contribution of each of the categories to the total number of retreatment cases? If yes, how do you explain these changes over time? Variations in the factors that drive the TB epidemic, including TB control efforts and TB treatment regiments Variations in the prevalence of drug-resistance TB Variations in notification policy/practice in these categories over time Variations in the amount of misclassification between the categories over time Don't know Other causes - please specify
36 Relapse Retreat / Subnational New All Pulm New SS+ Pulm / / /
37 A - Proportion of all TB cases that are new In the last year, how do the proportions for each of the admin 1 level areas compare with the national average? / New All
38 A - Proportion of all TB cases that are new If you identified a big variation, how do you explain that? Differences in factors that drive the TB epidemic across admin 1 areas, including risk factors, TB control efforts, proportion of drug-resistant TB Misclassification problems across admin 1 areas (i.e. retreatment cases wrongly classified as new cases) Don't know Other causes - please specify / New All
39 B - Proportion of new cases that are pulmonary In the last year, how do the proportions for each of the admin 1 level areas compare with the national average? / Pulm New
40 B - Proportion of new cases that are pulmonary If you identified a big variation, how do you explain that? Differences in extra-pulmonary diagnostic capacity across admin 1 areas Differences in the age structure of TB cases across admin 1 areas Differences in HIV prevalence across admin 1 areas Differences in the notification policy or practice across admin 1 areas Differences in misclassification problems across admin 1 areas Don't know Other causes - please specify / Pulm New
41 C - Proportion of all pulmonary cases that are smear positive In the last year, how do the proportions for each of the admin 1 level areas compare with the national average? / SS+ Pulm
42 C - Proportion of all pulmonary cases that are smear positive If you identified a big variation, how do you explain that? Differences in capacity to perform smear examination across admin 1 areas Differences in the age structure of TB cases across admin 1 areas Differences in HIV prevalence across admin 1 areas Differences in the notification policy or practice across admin 1 areas Differences in misclassification problems across admin 1 areas Don't know Other causes - please specify / SS+ Pulm
43 2.3 Do you have data on TB- HIV co-morbidity cases?
44 2.3 Do you have data on TB-HIV co-morbidity cases? & 2.3.2: Is there a national TB-HIV surveillance system? If yes, since when? Yes, data on the results of HIV testing of TB patients is collected as part of the main TB surveillance system Yes, data on the results of HIV testing of TB patients is collected in a parallel system (e.g. HIV sentinel surveillance system) No, there is no system to record results of HIV testing of TB patients Don't know
45 2.3 Do you have data on TB-HIV co-morbidity cases? 2.3.3: If yes, have there been variations in the proportion of registered TB patients with HIV+ results over the last 5 years? Yes, and they are mainly due to real changes in the proportion of coinfected patients Yes, and they are mainly due to changes in the proportion of TB patients that are tested for HIV Yes, and they are mainly due to changes in the recording of this information in the system Yes, and they are due to a combination of the above mentioned causes No, the proportion has not varied much Don't know
46 2.3 Do you have data on TB-HIV co-morbidity cases? & 2.3.5: Have you ever done a national survey for the prevalence of HIV positive patients among a representative sample of your registered TB patients? What was the result of your last national survey? Yes, one survey Yes, more than one survey No Don't know
47 2.4 Do you have data on MDR-TB cases?
48 2.4 Do you have data on MDR-TB cases? & 2.4.2: Is there a national MDR-TB surveillance system? If yes, since when? Yes, data on MDR-TB patients is collected as part of the main TB surveillance system Yes, data on MDR-TB patients is collected in a parallel system No, there is no system to record MDR-TB patients data Don't know
49 2.4 Do you have data on MDR-TB cases? 2.4.3: If yes, have there been variations in the proportion of registered TB patients that have MDR-TB over the last 5 years? Yes, and they are mainly due to real changes in the proportion of MDR-TB patients Yes, and they are mainly due to changes in the proportion of TB patients that have access to culture and/or drug sensitivity testing Yes, and they are mainly due to changes in the recording of this information in the system Yes, and they are due to a combination of the above mentioned causes No, the proportion has not varied much Don't know
50 2.4.4 & 2.4.5: Have you ever done a national survey for the prevalence of MDR-TB patients among a representative sample of your registered TB patients? What was the result of your last national survey? Yes, one survey Yes, more than one survey No 2.4 Do you have data on MDR-TB cases? Don't know
51 How useful are the data? Continue on Thank you!
2. Are data reliable and complete?
2. Are data reliable and complete? Mehran Hosseini WHO/HQ/Stop TB TB monitoring and evaluation unit hosseinism@who.int Data quality: what is it? 1. Data Quality: The Accuracy Dimension Jack E. Olson "Data
More informationRegional & National Partnerships to Stop TB in the Eastern Mediterranean Region-lessons learnt
Regional & National Partnerships to Stop TB in the Eastern Mediterranean Region-lessons learnt Dr. Mohamed Awad Tag Eldin Chair, Coordinating Board of the Eastern Mediterranean Partnership to Stop TB Eastern
More informationDr Ghazi Yehia OIE Regional Representative for the Middle East
Foot and mouth disease control strategies in North Africa and the Middle East The current situation Asuncion, Paraguay, 24-26 June 2009 Dr Ghazi Yehia OIE Regional Representative for the Middle East Acknowledgements
More informationMaternal Health in Arab States
Maternal Health in Arab States Improving Maternal Health Improving maternal health is MDG number 5 and it has two targets Target A that measures reduction in maternal mortality ratio (MMR) and attended
More informationAssessment of Surveillance data WORKBOOK. Country
Assessment of Surveillance data WORKBOOK Country Persons filling in this workbook Name Functional title (e.g. ) Highest educational degree Number of years working in TB control programme Email address
More informationyour liver Care for Think about hepatitis
your liver Care for Think about hepatitis World Hepatitis Day 2015 What is hepatitis? Hepatitis is the common name for all inflammatory diseases of the liver. Liver inflammation is most often caused by
More informationWHO Health Statistics : Applied through the lens of the Global Monitoring Framework for the Prevention and Control of Noncommunicable Diseases
WHO Health Statistics : Applied through the lens of the Global Monitoring Framework for the Prevention and Control of Noncommunicable Diseases Dr E Tursan d'espaignet Prevention of Noncommunicable Diseases
More informationThe Jordan University Hospital, Amman, Jordan
The Jordan University Hospital, Amman, Jordan Pneumococcal vaccine and overcoming the immunization rift Najwa Khuri-Bulos JUH Amman, Jordan February 13 2008 Pneumococcal disease burden 1.6 million deaths
More informationBrigitte Khoury, Ph.D. Director, Arab Regional Center for Research, Training and Policy Making in Mental Health Dept. of Psychiatry, American
Brigitte Khoury, Ph.D. Director, Arab Regional Center for Research, Training and Policy Making in Mental Health Dept. of Psychiatry, American University of Beirut UNESCO s 2010 Science Report on Scientific
More informationFoot and Mouth Disease Middle East situation Summary of Answers to the Questionnaire Beirut, Lebanon, 7 9 April 2009
Foot and Mouth Disease Middle East situation Summary of Answers to the Questionnaire Beirut, Lebanon, 7 9 April 2009 Dr Pierre Primot OIE for the Middle East Purpose of the Questionnaire The purpose of
More informationDevelopment of a Regional Framework of Action in obesity Prevention in the Eastern Mediterranean Region
Development of a Regional Framework of Action in obesity Prevention in the Eastern Mediterranean Region Ayoub Al Jawaldeh; Regional Adviser, WHO- EMRO 2011 Political declaration on NCDs, Sustainable Development
More informationProgrammatic Feasibility of Measles Elimination
Programmatic Feasibility of Measles Elimination World Health Organization Eastern Mediterranean Region June 2010 Acronyms: EMR Eastern Mediterranean Region of the World Health Organization 1 EMRO EPI GAVI
More informationThe Suggested World Wide Halal Model
The Suggested World Wide Halal Model Assoc. Prof. Mariam Abdul Latif Universiti Malaysia Sabah, Malaysia The Second Gulf Conference on Halal Industry and its Services 22-24 January, 2013 Crown Plaza Hotel,
More informationApplication of the Onion model to assess the extent of missing tuberculosis cases by the National Programmes
Application of the Onion model to assess the extent of missing tuberculosis cases by the National Programmes Dr Amal Bassili Stop TB unit, WHO, Regional Office for the Eastern Mediterranean Surveillance
More informationFoot and mouth disease control strategies in North Africa and the Middle East the current
1. Title, names and addresses of authors Foot and mouth disease control strategies in North Africa and the Middle East the current situation G. Yehia (1), P. Primot (1) (1) OIE Regional Representation
More informationBreast Cancer in the Eastern Mediterranean Region A Burden with Potential. King Hussein Cancer Center
Breast Cancer in the Eastern Mediterranean Region A Burden with Potential Presented by: Mahmoud M. Sarhan, MD, MMM, CPE CEO & Director General Presented at: International Symposium on Breast Cancer in
More informationNONCOMMUNICABLE DISEASES IN THE MIDDLE EAST AND NORTH AFRICA:
NONCOMMUNICABLE DISEASES IN THE MIDDLE EAST AND NORTH AFRICA: Addressing Risk Factors Among Young People Is Key to Curbing the Epidemic DATA SHEET DECEMBER 201 www.prb.org Tobacco Use Is Widespread Among
More informationThe FAO/OIE FMD Global Control Strategy Joseph Domenech, OIE on behalf of the joint FAO/OIE GF TADs PPR Working Group
The FAO/OIE FMD Global Control Strategy Joseph Domenech, OIE on behalf of the joint FAO/OIE GF TADs PPR Working Group 5 th meeting of the GF TADs Regional Steering Committee for Europe October 8 th -9th
More informationProgress report on HIV/AIDS
Regional Committee for the EM/RC54/INF.DOC.1 Eastern Mediterranean May 2007 Fifty-fourth Session Original: Arabic Agenda item 4 (a) Progress report on HIV/AIDS Contents 1. Introduction: From 3 by 5 towards
More informationProgress report on the achievement of the health-related Millennium Development Goals and global health goals after 2015
Regional Committee for the Eastern Mediterranean Fifty-ninth session Provisional agenda item 2 (c) EM/RC59/INF.DOC.3 July 2012 Progress report on the achievement of the health-related Millennium Development
More informationEastern Mediterranean Region Framework for health information systems and core indicators for monitoring health situation and health system
Eastern Mediterranean Region Framework for health information systems and core indicators for monitoring health situation and health system performance 2017 Eastern Mediterranean Region Framework for
More informationAcquired immuno-deficiency syndrome (AIDS) in the Eastern Mediterranean Region
WHO-EMlRC/INF.DOC. Acquired immuno-deficiency syndrome (AIDS) in the Eastern Mediterranean Region. Introduction By the end of 00, an estimated 0 million people in the world were living with HIV/AIDS, million
More informationBRCA Testing in Ovarian cancer Arabic Approach
BRCA Testing in Ovarian cancer Arabic Approach Khalid El Khalfaoui Departement of Gynecology and Gyn Oncology Wermelskirchen Hospital 25.04.2018 Krankenhaus Wermelskirchen GmbH I 1 Development of cancer
More informationProgress report on. Eradication of poliomyelitis
Regional Committee for the EM/RC52/INF.DOC.2 Eastern Mediterranean August 2005 Fifty-second Session Original: Arabic Agenda item 4 (b) Progress report on Eradication of poliomyelitis Contents 1. Introduction...1
More informationBDS, MSc, MSPH, MHPE, FFPH, ScD. Associate Prof. of Epidemiology and Biostatistics. Associate Prof. Medical Education
Yusuf Al-Gau Gau d BDS, MSc, MSPH, MHPE, FFPH, ScD Associate Prof. of Epidemiology and Biostatistics Associate Prof. Medical Education Jordan University of Science & Technology Alarming high prevalence
More informationThe Need for More and Better Palliative Care in Muslim-Majority Countries
The Need for More and Better Palliative Care in Muslim-Majority Countries Joe Harford, Ph.D. Center for Global Health National Cancer Institute Email: harfordj@nih.gov Deena M. Aljawi King Faisal Specialist
More informationDiabetes management: lessons from around the globe MENA. J. Belkhadir (Morocco)
Diabetes management: lessons from around the globe MENA J. Belkhadir (Morocco) Managing Diabetes: challenges faced in the MENA Region and strategies developed Jamal Belkhadir Diabetologist, Endocrinologist
More informationThe study was cross-sectional, conducted during the academic year 2004/05.
Tobacco use is one of the chief preventable risk factors of some 25 noncommunicable diseases, many of which are eventually fatal. The World Health Organization (WHO) attributes some 4 million deaths annually
More informationThe global progress towards poliomyelitis
Communicable diseases Poliomyelitis eradication The global progress towards poliomyelitis eradication in 2014 was substantial. However, the disease remains endemic in the Region. Of the 215 polio globally
More informationThe emerging face of the HIV epidemic in the Middle East and North Africa
REVIEW C URRENT OPINION The emerging face of the HIV epidemic in the Middle East and North Africa Ghina R. Mumtaz a, Gabriele Riedner b, and Laith J. Abu-Raddad a,c,d Purpose of review A volume of quality
More informationTempo effect of child mortality rate in the MENA region from the perspective of Millennium Development Goals
Source: The World Bank, 2008 Tempo effect of child mortality rate in the MENA region from the perspective of Millennium Development Goals Ardeshir Entezari 1 Nader Motie Haghshenas 1 Somayeh Karami Nia
More informationGender Overview of OIC Member Countries
1 st Meeting of the OIC-StatCom TCE on Gender Related Issues 21-22 January 2013 Ankara, Turkey STATISTICAL, ECONOMIC AND SOCIAL RESEARCH AND TRAINING CENTRE FOR ISLAMIC COUNTRIES O R G A NIZATION O F I
More informationWHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010
WHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010 Task Force on TB Impact Measurement Mandate To produce a robust,
More informationCurrent Trends in ODS Production and Supply
6 5 4 3 2 1 1995 1997 1999 21 23 25 27 29 Current Trends in ODS Production and Supply Erik Pedersen Tenth Annual Financial Agents Workshop The World Bank Washington, D.C. June 27 to June 28, 26 Apparent
More informationTuberculosis: The Effect of Limited Screening Program on the Epidemiology of TB
Bahrain Medical Bulletin, Vol. 34, No. 3, September 2012 Tuberculosis: The Effect of Limited Screening Program on the Epidemiology of TB Safaa AbdulAziz Alkhawaja, MD, CABM* Saeed Hasan AlSafaar, MD, MRCP**
More informationProgress report on emerging and re-emerging diseases including dengue and dengue haemorrhagic fever
Regional Committee for the Eastern Mediterranean Sixty-third session Provisional agenda item 3(c) EM/RC63/INF.DOC 2 Rev.2 September 2016 Introduction Progress report on emerging and re-emerging diseases
More informationVIDRL & WHO Measles IgM Proficiency Panel Final Report Prepared by Jennie Leydon, Michaela Riddell & Dr Mike Catton Director VIDRL
VIDRL & WHO Measles IgM Proficiency Panel 00702 Final Report Prepared by Jennie Leydon, Michaela Riddell & Dr Mike Catton Director VIDRL Table of Contents Tables and Figures... 3 Abbreviations... 4 Introduction...
More informationProgress report on eradication of poliomyelitis: regional implications of the endgame strategy
Regional Committee for the Eastern Mediterranean Sixtieth session Provisional agenda item 3 (a) August 2013 Progress report on eradication of poliomyelitis: regional implications of the endgame strategy
More informationEastern Mediterranean Health Journal, Vol. 10, No. 6,
Eastern Mediterranean Health Journal, Vol. 10, No. 6, 2004 789 Invited paper Overweight and obesity in the Eastern Mediterranean Region: can we control it? A.O. Musaiger 1 SUMMARY Obesity has become an
More informationDownloaded from:
Saba, HF; Kouyoumjian, SP; Mumtaz, GR; Abu-Raddad, LJ (2013) Characterising the progress in HIV/AIDS research in the Middle East and North Africa. Sexually transmitted infections, 89 Sup. iii5-9. ISSN
More informationWhat is the MENA face of HIV/AIDS?
What is the MENA face of HIV/AIDS? Laith J. Abu-Raddad Weill Cornell Medical College - Qatar, Cornell University, Doha, Qatar Fred Hutchinson Cancer Research Center, Seattle, Washington, U.S.A The MENA
More informationSeeking Opportunities from Complex Regulatory Challenges for Halal Cosmetic Products in ASEAN Market
Seeking Opportunities from Complex Regulatory Challenges for Halal Cosmetic Products in ASEAN Market Ahmad Shaiful Alwi b Md Nor, RPh Principal Consultant Asas Avedis Consultancy BACKGROUND INFORMATION
More informationStrengthening the institutional capacity of NSOs to produce data and address the current gaps
Economic and Social Commission for Western Asia (UNESCWA) Improving gender statistics for advancement of gender equality and women s empowerment: an inter-regional workshop 6 8 June 2016, UNESCAP, Bangkok,
More informationAnnex 3. Meetings held in the Eastern Mediterranean Region, 2014
Annex 3. Meetings held in the Eastern Mediterranean Region, Statutory and advisory meetings Expanded meeting for members of the Advisory Committee on Health Research to discuss integrating research in
More informationEvaluation of Asthma Management in Middle EAst North Africa Adult population
STUDY REPORT SUMMARY Evaluation of Asthma Management in Middle EAst North Africa Adult population Descriptive study on the management of asthma in an asthmatic Middle East Africa adult population Background/Rationale:
More informationTOBACCO USE IN OIC COUNTRIES: PROSPECTS AND CHALLENGES
ORGANISATION OF THE ISLAMIC CONFERENCE STATISTICAL, ECONOMIC AND SOCIAL RESEARCH AND TRAINING CENTRE FOR ISLAMIC COUNTRIES OIC OUTLOOK March 2010 TOBACCO USE IN OIC COUNTRIES: PROSPECTS AND CHALLENGES
More informationNature Genetics: doi: /ng Supplementary Figure 1. Country distribution of GME samples and designation of geographical subregions.
Supplementary Figure 1 Country distribution of GME samples and designation of geographical subregions. GME samples collected across 20 countries and territories from the GME. Pie size corresponds to the
More informationHoda Rashad and Hassan Zaky With support from Iman Mostafa and Mohamed Salem 1
Addressing fertility concerns in Mashreq countries: An illustrative study of Egypt fertility plateau presented to Seminar on Fertility Trends and Prospects in the Arab Countries Paris 18 Dec. 2012 By Hoda
More informationVOLUME 4 ISSUE 1. AIDS and sexually transmitted diseases. theme stigma and discrimination in healthcare
VOLUME 4 ISSUE 1 January 2012 DCD Bulletin Division of Communicable Disease Control DCD Bulletin This quarterly bulletin presents important news, events and announcements from programmes of Division of
More informationHealth Challenges and their Determinants in the EMR/MENA
Health Challenges and their Determinants in the EMR/MENA Sameen Siddiqi, Regional Adviser, Health Policy and Planning, WHO EMRO The Middle East and North Africa Health Policy Forum Conference on Better
More informationWild Poliovirus*, 03 Aug 2004 to 02 Aug 2005
Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild virus type 1 Wild virus type 3 Wild virus type 1 & 3 Endemic countries Re-established transmission countries Case or outbreak following importation *Excludes
More informationVOLUME 8 ISSUE 1. Preparedness and readiness measures for Ebola Virus Disease (EVD) stepped up
VOLUME 8 ISSUE 1 January 2015 DCD Bulletin Department of Communicable Diseases DCD Bulletin This quarterly bulletin presents important news, events and announcements from programmes of Department of Communicable
More informationEstimates of TB incidence, prevalence and mortality. Philippe Glaziou Cairo, October 2009
Estimates of TB incidence, prevalence and mortality Philippe Glaziou Cairo, October 2009 Outline Main sources of information Incidence From incidence to prevalence From incidence to mortality TB/HIV MDR-TB
More informationProgramme news (HIV, TB, malaria and tropical diseases)
VOLUME 6 ISSUE 3 July 2013 DCD Bulletin Department of Communicable Diseases DCD Bulletin This quarterly bulletin presents important news, events and announcements from programmes of Department of Communicable
More informationitntx.org / /
itntx.org / info@itntx.org / /ITN2015 About ITN International Transplant Network (ITN) is a civil initiative actively engaged in different aspects and branches of organ donation and transplantation. It
More informationInfluenza is a highly infectious disease caused
review article Oman Medical Journal [2017], Vol. 32, No. 5: 359-364 Influenza Research in the Eastern Mediterranean Region: A Review Wasiq Khan 1, Amira S. El Rifay 2, Mamun Malik 1 and Ghazi Kayali 3,4
More informationStrategy for cancer prevention and control in the Eastern Mediterranean Region
Regional Committee for the EM/RC56/4 Eastern Mediterranean July 2009 Fifty-sixth Session Original: English Agenda item 6 (b) Technical paper Strategy for cancer prevention and control in the Eastern Mediterranean
More informationin the Eastern Mediterranean Region Prevention and control
in the Eastern Mediterranean Region Prevention and control 2012 2013 in the Eastern Mediterranean Region Prevention and control 2012 2013 WHO Library Cataloguing in Publication Data World Health Organization.
More informationStatus of Regulatory Infrastructure in Arab Countries. Tunis, 13 March 2013
Status of Regulatory Infrastructure in Arab Countries Tunis, 13 March 2013 CONTENTS IAEA Radiation Safety Standards Evaluating and Quantifying the Status of Radiation Safety Infrastructure Some IAEA activities
More informationSchedule of Benefits (REGIONAL-SEHA PRIME Plan_AL DURRA)
Plan Name Annual Benefit Limit Territorial Limit 1 REGIONAL-SEHA PPRIME Plan (AL DURRA) AED 5,000,000 Per Person Per Policy Year MENA Region* Extended to: Worldwide for (a) Emergencies (b) the Non-Elective
More informationReport of the Seminar on FMD Progressive Control. Pathway. 18 th December Beirut, Lebanon
1 Report of the Seminar on FMD Progressive Control. Pathway 18 th December 2012 Beirut, Lebanon 1. Introduction: i. The principal aim of the FMD Seminar was to discuss the preparation of national project
More informationThe Test-Curriculum Matching Analysis: Science
Appendix C The Test-Curriculum Matching Analysis: Science TIMSS went to great lengths to ensure that comparisons of student achievement across countries would be as fair and equitable as possible. The
More informationIntercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net
WHO-EM/MAL/367/E Summary report on the Intercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net Muscat, Oman 22 24 September 2011 World Health Organization 2012
More informationPharmaceuticals Import Summary Report. selected countries in MENA region
Pharmaceuticals Import Summary Report selected countries in MENA region Contents.. 3. 3. 3. 3.3....3 5. 5. 5. 6. 6. 6. Disclaimer Global Imports. Imports in MENA Focus Pharmaceutical Categries Vaccines
More informationEMPOWERING THE FUTURE DIGITAL CITIZENS
Session 3: Role of Industry / Technical Measures ITU REGIONAL STRATEGY WORKSHOP ON CHILD ONLINE PROTECTION (COP) FOR THE ARAB REGION: EMPOWERING THE FUTURE DIGITAL CITIZENS MINISTRY OF COMMUNICATIONS AND
More informationDietary adequacy of Egyptian children with autism
Dietary adequacy of Egyptian children with autism Presented by Dr. Nagwa Abdel Meguid Prof. of Human Genetics and special Needs, NRC,Egypt Head of the CONEM Egypt Child Brain Research Group Council for
More informationAnalysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),
Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF), 2008-2010 Claudio Politi and Oumar Sagna Department of Immunization Vaccines and Biologicals, World Health
More information&+.&~&~I+&~I EWRC43lINF.DOC.2 April 1996 REGIONAL COMMITTEE FOR THE EASTERN MEDITERRANEAN Original: Arabic Forty-third Session
WORLD HEALTH ORGANIZATION Qegional Office for the Eastern Mediterranean ORGANISATION MONDIALE DE LA SANTE Bureau regional de la Mediterranee orientale is+j@& _....r &+.&~&~I+&~I >, REGIONAL COMMITTEE FOR
More informationTB/HIV Project in the Philippines. Yumiko Yanase
TB/HIV Project in the Philippines Yumiko Yanase 1 TB situation in the Philippines Global rank: 9th Incidence (all): 296 Prevalence (all): 458 TB mortality (all): 49 New MDR-TB: 3.2% Case types notified
More informationVIMS Print and Fly: AFGHANISTAN
WHO Region: EMRO World Bank Income Group: Low-income GAVI Eligible: Countries in WHO Region: GAVI Phase III Eligible AFGHANISTAN, BAHRAIN, DJIBOUTI, EGYPT, IRAN, ISLAMIC REPUBLIC OF, IRAQ, JORDAN, KUWAIT,
More informationRegional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries
Summary report on the Regional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries Casablanca, Morocco 18 20 October
More informationEradication of poliomyelitis
Regional Committee for the Eastern Mediterranean August 2010 Fifty-seventh Session Original: Arabic Agenda item 2 (b) Progress report on Eradication of poliomyelitis Contents 1. Introduction...1 2. Current
More informationAppendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479
Appendix F The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479 TIMSS went to great lengths to ensure that comparisons of student achievement across
More informationמדינת ישראל. Tourist Visa Table
Updated 23/05/2017 מדינת ישראל Tourist Visa Table Tourist visa exemption is applied to national and official passports only, and not to other travel documents. Exe = exempted Req = required Press the first
More informationEMRO May (EMVAP) Action
EMRO Framework for implementation Global Vaccine May Eastern Mediterr ranean Vaccine Action Plan 2016-2020 (EMVAP) A Framework for Implementation of Global Vaccine Action Plan (GVAP) Eastern Mediterranean
More informationEstimating TB burden. Philippe Glaziou World Health Organization Accra, Ghana
Estimating TB burden Philippe Glaziou World Health Organization Accra, Ghana Outline Basic facts about TB epidemiology What should we expect with regards TB burden over time? Main indicators of TB disease
More informationRegional strategy for the prevention and control of sexually transmitted infections
Regional Committee for the EM/RC55/6 Eastern Mediterranean August 2008 Fifty-fifth Session Original: Arabic Agenda item 6 (c) Technical paper Regional strategy for the prevention and control of sexually
More informationReligious Festivals and Influenza. Hong Kong (SAR) China. *Correspondence to:
Religious Festivals and Influenza Alice P.Y. Chiu 1, Qianying Lin 1, Daihai He 1,* 1 Department of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong (SAR) China *Correspondence to: daihai.he@polyu.edu.hk
More informationExposure to second-hand smoke in selected public places in the WHO Eastern Mediterranean Region
WHO-EM/TFI/074/E Exposure to second-hand smoke in selected public places in the WHO Eastern Mediterranean Region Report of a pilot study WHO EM/TFI/074/E Exposure to second hand smoke in selected public
More informationSHOKI AL DOBAI, Ph.D. Pesticide Directorate, GDPP Ministry of Agriculture & Irrigation, Yemen
SHOKI AL DOBAI, Ph.D. Pesticide Directorate, GDPP Ministry of Agriculture & Irrigation, Yemen Problems of vector borne diseases Malaria; Leishmaniasis; Rift Valley Fever; Dengue Fever; Other vectors/ Pest
More information12-14 October 2009, WHO, Geneva
The 7 th WHO Global Measles and Rubella Laboratory Network Meeting 12-14 October 2009, WHO, Geneva Summary and Recommendations Global and Regional Update The measles and rubella laboratory network (LabNet)
More informationAppendix F: Test-Curriculum Matching Analysis
Appendix F: Test-Curriculum Matching Analysis TIMSS went to great lengths to ensure that comparisons of student achievement across countries would be as fair and equitable as possible. The TIMSS 2015 Assessment
More informationRegional Action Plan for the Implementation of the Global Strategy for Viral Hepatitis Draft for consultation (2)
Regional Action Plan for the Implementation of the Global Strategy for Viral Hepatitis 2017 2021 Draft for consultation (2) WHO Regional Office for the Eastern Mediterranean 1 CONTENTS I Introduction...
More informationDeveloping Gender Related Statistics: Indonesia Experience
Developing Gender Related Statistics: Indonesia Experience Wynandin Imawan wynandin@bps.go.id Kick Off Meeting of Technical of Experts on Gender Related Statistics Ankara, 21-22 January 2013 22 JANUARY
More informationANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for tuberculosis programme managers
ANALYSIS AND USE OF HEALTH FACILITY DATA Guidance for tuberculosis programme managers WORKING DOCUMENT SEPTEMBER 2018 World Health Organization 2018 All rights reserved. This is a working document and
More informationמדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.
Updated 25/05/2015 ישראל Tourist Visa Table Tourist visa exemption is applied to national and official passports only, and not to other travel documents. (C) Bearers of official passports requiring tourist
More informationEastern Mediterranean Region
Eastern Mediterranean Region I. Introduction The WHO Eastern Mediterranean Region comprises 23 countries. It has a population of 597 million people 1. It is a widely diversified region in which countries
More informationRaising Halal Cosmetic Awareness among the respective Consumers
Raising Halal Cosmetic Awareness among the respective Consumers Bahman Hajipour Department of Accounting and Management - Associate Professor - Shahid Beheshti University Shahid Beheshti University, Evin,
More informationEastern Mediterranean Region
Eastern Mediterranean Region Afghanistan 16 63 15 45 2 141 Adult (15+) 9 16 8 468 11 935 % Urban 15.6 18.3 2. % Rural 84.3 81.8 8. Life expectancy at birth, 199-1995 : 43 (males), 44 (females) Infant mortality
More informationHalal Taiwan: Emerging Player in the Global Halal Market
Halal Taiwan: Emerging Player in the Global Halal Market KHAIRUL AKMALIAH ADHAM FACULTY OF ECONOMICS AND MUAMALAT, UNIVERSITI SAINS ISLAM MALAYSIA MOFA 2017 VISITING SCHOLAR, TAIWAN-ASEAN STUDIES CENTER,
More informationMiddle East & North Africa
Public Disclosure Authorized Public Disclosure Authorized Public Disclosure Authorized Public Disclosure Authorized 41956 Middle East & North Africa Gender Overview Talajeh Livani 27 The International
More informationMDG related to Maternal and Child Health Status in Lebanon: an update. Presented by Dr Alissar Rady NPO,WHO Beirut NCPNN meeting, 21/11/ 2008
MDG related to Maternal and Child Health Status in Lebanon: an update Presented by Dr Alissar Rady NPO,WHO Beirut NCPNN meeting, 21/11/ 2008 Where do Millennium Development Millennium Summit Goals come
More informationPoliomyelitis Eradication
WHO-EM/POL/350/E Poliomyelitis Eradication in the Eastern Mediterranean Region Progress Report 2006 Cairo 2007 Contents Foreword...4 1 Introduction...6 2 Current situation in the Eastern Mediterranean
More informationQ3 Statistical Report 2017
Q Statistical Report 07 Summary Overall Quarter Observations During this quarter, the Helpline saw a steady increase in number calls rising from 7 in July to 7 in September. We had an unprecedented 94
More informationESMO SUMMIT MIDDLE EAST 2018
ESMO SUMMIT MIDDLE EAST 2018 Management of Prostate Cancer in the Middle East Deborah Mukherji, MD, AUBMC, Beirut, Lebanon (Fadi Farhat, MD, MHHM) 6-7 April 2018, Dubai, UAE CONFLICT OF INTEREST DISCLOSURE
More informationFood fortification to combat micronutrient deficiency disorders
WHO-EMlRC51nNF.DOC.4 Food fortification to combat micronutrient deficiency disorders 1_ Introduction Dietary supplements and food fortification have permitted humans to consume micronutrients in amounts
More informationTHE HEART OF THE VETERAN BIG DATA AND SURVEY APPROACHES TO HEALTH SERVICES RESEARCH
THE HEART OF THE VETERAN BIG DATA AND SURVEY APPROACHES TO HEALTH SERVICES RESEARCH Where Research Meets the Road: Using science to support Veterans in their journey to health and resilience TexVet Symposium
More informationPredictive statistical modelling approach to estimating TB burden. Sandra Alba, Ente Rood, Masja Straetemans and Mirjam Bakker
Predictive statistical modelling approach to estimating TB burden Sandra Alba, Ente Rood, Masja Straetemans and Mirjam Bakker Overall aim, interim results Overall aim of predictive models: 1. To enable
More information